《2020年韩国高血压情况说明书：基于全国人口数据的分析》
Korea hypertension fact sheet 2020: analysis of nationwide population-based data.
作者信息
Kim Hyeon Chang, Cho So Mi Jemma, Lee Hokyou, Lee Hyeok-Hee, Baek Jongmin, Heo Ji Eun
机构信息
Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 03722, South Korea.
出版信息
Clin Hypertens. 2021 Mar 15;27(1):8. doi: 10.1186/s40885-021-00166-2.
BACKGROUND
The Korean Society of Hypertension has published the Korea Hypertension Fact Sheet 2020 to provide an overview of the magnitude and management status of hypertension and their recent trends.
METHODS
The Fact Sheets were based on the analyses of Korean adults aged 20 years or older of the 2007-2018 Korea National Health and Nutrition Examination Survey (KNHANES) and the 2002-2018 National Health Insurance Big Data (NHI-BD).
RESULTS
Currently, the population average of systolic/diastolic blood pressure was 118/76 mmHg in Korean adults aged 20 years or older showing little change in the recent decade. However, the number of people with hypertension increased steadily, exceeding 12.0 million. Indeed, the number of people diagnosed with hypertension increased from 3.0 million in 2002 to 9.7 million in 2018. During the same period, the number of people using antihypertensive medication increased from 2.5 million to 9.0 million, and the number of people adherent to treatment increased from 0.6 million to 6.5 million. Hypertension awareness, treatment, and control rates increased rapidly until 2007, but showed plateaued thereafter. In 2018, the awareness, treatment, and control rates of hypertension among all adults were 67, 63, and 47%, respectively. However, the awareness and treatment rates were only 17 and 14% among adults aged 20 to 39 years old with hypertension. Among patients treated for hypertension, 61% of them were also using glucose-lowering or lipid-lowering drugs. Among antihypertensive prescriptions, 41% of the patients received monotherapy, 43% received dual therapy, and 16% received triple or more therapy. The most commonly prescribed antihypertensive medication was angiotensin receptor blockers, followed by calcium channel blockers and diuretics.
CONCLUSION
To achieve further improvement in management of hypertension, we need to encourage awareness and treatment in young adults. It is required to develop tailored prevention and management strategies that are appropriate for and inclusive of various demographics.
背景
韩国高血压学会发布了《2020年韩国高血压情况说明书》，以概述高血压的严重程度、管理状况及其近期趋势。
方法
这些情况说明书基于对2007 - 2018年韩国国家健康与营养检查调查（KNHANES）中20岁及以上韩国成年人以及2002 - 2018年国家健康保险大数据（NHI - BD）的分析。
结果
目前，20岁及以上韩国成年人的收缩压/舒张压人群平均值为118/76 mmHg，近十年来变化不大。然而，高血压患者数量稳步增加，超过了1200万。事实上，被诊断患有高血压的人数从2002年的300万增加到2018年的970万。在此期间，使用抗高血压药物的人数从250万增加到900万，坚持治疗的人数从60万增加到650万。高血压知晓率、治疗率和控制率在2007年前迅速上升，但此后趋于平稳。2018年，所有成年人中高血压的知晓率、治疗率和控制率分别为67%、63%和47%。然而，在20至39岁患有高血压的成年人中，知晓率和治疗率仅为17%和14%。在接受高血压治疗的患者中，61%的人还使用降糖或降脂药物。在抗高血压处方中，41%的患者接受单药治疗，43%接受联合治疗，16%接受三联或更多药物治疗。最常用的抗高血压药物是血管紧张素受体阻滞剂，其次是钙通道阻滞剂和利尿剂。
结论
为了进一步改善高血压管理，我们需要鼓励年轻人提高知晓率并接受治疗。需要制定适合并涵盖不同人群的定制化预防和管理策略。
Zotero 插件